Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Hyseq presents gene product with potential application to vaccine development

Dec. 28, 1998

Disposition of L-732351, a semisynthetic macrolide immunosuppressant, in animals

Dec. 23, 1998

FDA approves first Lyme disease vaccine

Dec. 22, 1998

Abgenix completes phase II clinical trial in GVHD

Dec. 22, 1998

Abgenix and RCT enter CD45RB antibody collaboration

Dec. 21, 1998

Novartis updates status of immunosuppressive agent

Dec. 17, 1998

SmithKline Beecham and Ribi announce positive HBV phase III trial data

Dec. 16, 1998

MedImmune and BioTransplant initiate two new clinical studies of MEDI-507

Dec. 16, 1998

Vanguard Medica takes on development of imiquimod analogue

Dec. 15, 1998

U.S. patent issues to Alexion, paving the way to improved xenotransplantation technology

Dec. 15, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...